Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone discontinuation study in people with intellectual disability and challenging behavior
NL-OMON43644Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of risperidone in behavioral disorder and intellectual disability (ID) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Aberrant Behavior Checklist irritability subscale. Planned start Nov 2015; status: not yet recruiting.
02
Drugs
risperidone
03
Conditions
behavioral disorderintellectual disability (ID)
Beyond the preview
Go deeper on NL-OMON43644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43644.